CIMNET Announces Pharmaceutical Software Compliance.

Business Editors

ROBESONIA, Pa.--(BUSINESS WIRE)--April 4, 2002

CIMNET(R), Inc. (OTC BB:CIMK) a leading developer, marketer, and integrator of manufacturing execution software today announced that their Factelligence(TM) Manufacturing Execution System (MES) will be made fully CFR21 Part 11 complaint within 90 days to suit the pharmaceutical and regulated industries.

Factelligence(TM) is a web-based MES designed to assist manufacturers in the time taken for regulatory compliance and the introduction of new products. It creates full visibility into manufacturing operations for factory decision makers and external supply chain systems.

It also builds an environment where recipes, instructions, batch records and material traceability are electronically managed and distributed.

"The addition of procedural management, electronic signatures and full batch record keeping to the broad range of existing features makes the Factelligence MES a compelling solution for regulated industries," stated John Richardson, CEO of CIMNET. "Good Manufacturing Practices can be planned and executed with the new modules. This will also allow our food customers to manage their HACCP systems with a practical and secure software tool."

About CIMNET: CIMNET designs, markets and integrates software for manufacturing facilities. CIMNET's products allow manufacturing companies to schedule and monitor work flow in real time and reduce operating costs by improving quality of products being produced.

CIMNET's proprietary products, Factelligence(TM), FOLDERS(TM), Infolink and DNC Professional(TM), are used by discrete and process manufacturers in the aerospace, automotive, pharmaceutical, medical devices, food and beverage and consumer packaged goods industries. For more information about CIMNET products or services, go to their website at www.cimnet.com.

This press release contains certain forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934. When used in this release, the words "believe," "anticipate," "think," "intend," "plan," "will be," "expect," and similar expressions identify such forward-looking statements.

Such statements regarding future events and/or the future financial performance of the Company are subject to certain risks and uncertainties which could cause actual events or the actual future results of the Company to differ materially from any forward-looking statement.

Such risks and uncertainties may be detailed from time to time in the Company's reports or registration statements filed with the Securities and Exchange Commission.

In light of the significant risks and uncertainties inherent in the forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by the Company or any other person that the objectives and plans of the Company will be achieved.